170 related articles for article (PubMed ID: 34839347)
1. SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer.
Yang Y; He J; Zhang B; Zhang Z; Jia G; Liu S; Wu T; He X; Wang N
Cell Death Dis; 2021 Nov; 12(12):1108. PubMed ID: 34839347
[TBL] [Abstract][Full Text] [Related]
2. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation.
Infantino V; Iacobazzi V; Menga A; Avantaggiati ML; Palmieri F
Biochim Biophys Acta; 2014 Nov; 1839(11):1217-1225. PubMed ID: 25072865
[TBL] [Abstract][Full Text] [Related]
3. The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
Mosaoa R; Kasprzyk-Pawelec A; Fernandez HR; Avantaggiati ML
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499062
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis.
Zhang R; Peng X; Du JX; Boohaker R; Estevao IL; Grajeda BI; Cox MB; Almeida IC; Lu W
Cancer Res; 2023 Nov; 83(22):3739-3752. PubMed ID: 37695315
[TBL] [Abstract][Full Text] [Related]
5. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial citrate carrier SLC25A1 is a dosage-dependent regulator of metabolic reprogramming and morphogenesis in the developing heart.
Ohanele C; Peoples JN; Karlstaedt A; Geiger JT; Gayle AD; Ghazal N; Sohani F; Brown ME; Davis ME; Porter GA; Faundez V; Kwong JQ
bioRxiv; 2023 May; ():. PubMed ID: 37292906
[TBL] [Abstract][Full Text] [Related]
7. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
8. The Mitochondrial Citrate Carrier (SLC25A1) Sustains Redox Homeostasis and Mitochondrial Metabolism Supporting Radioresistance of Cancer Cells With Tolerance to Cycling Severe Hypoxia.
Hlouschek J; Hansel C; Jendrossek V; Matschke J
Front Oncol; 2018; 8():170. PubMed ID: 29888201
[TBL] [Abstract][Full Text] [Related]
9. MRPL35 Is Up-Regulated in Colorectal Cancer and Regulates Colorectal Cancer Cell Growth and Apoptosis.
Zhang L; Lu P; Yan L; Yang L; Wang Y; Chen J; Dai J; Li Y; Kang Z; Bai T; Xi Y; Xu J; Sun G; Yang T
Am J Pathol; 2019 May; 189(5):1105-1120. PubMed ID: 30862482
[TBL] [Abstract][Full Text] [Related]
10. Combined D2-/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment.
Mühlhausen C; Salomons GS; Lukacs Z; Struys EA; van der Knaap MS; Ullrich K; Santer R
J Inherit Metab Dis; 2014 Sep; 37(5):775-81. PubMed ID: 24687295
[TBL] [Abstract][Full Text] [Related]
11. A case report of an intermediate phenotype between congenital myasthenic syndrome and D-2- and L-2-hydroxyglutaric aciduria due to novel SLC25A1 variants.
Li W; Zhang M; Zhang L; Shi Y; Zhao L; Wu B; Li X; Zhou S
BMC Neurol; 2020 Jul; 20(1):278. PubMed ID: 32660532
[TBL] [Abstract][Full Text] [Related]
12. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
13. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
[TBL] [Abstract][Full Text] [Related]
14. A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
Cohen I; Staretz-Chacham O; Wormser O; Perez Y; Saada A; Kadir R; Birk OS
Am J Med Genet A; 2018 Feb; 176(2):330-336. PubMed ID: 29226520
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA hsa_circRNA_102209 promotes the growth and metastasis of colorectal cancer through miR-761-mediated Ras and Rab interactor 1 signaling.
Li C; Zhou H
Cancer Med; 2020 Sep; 9(18):6710-6725. PubMed ID: 32706154
[TBL] [Abstract][Full Text] [Related]
16. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells.
Pan T; Liu J; Xu S; Yu Q; Wang H; Sun H; Wu J; Zhu Y; Zhou J; Zhu Y
Theranostics; 2020; 10(2):516-536. PubMed ID: 31903135
[No Abstract] [Full Text] [Related]
17. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
18. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7.
Zeng K; Chen X; Xu M; Liu X; Hu X; Xu T; Sun H; Pan Y; He B; Wang S
Cell Death Dis; 2018 Apr; 9(4):417. PubMed ID: 29549306
[TBL] [Abstract][Full Text] [Related]
19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
20. JMJD2B-induced amino acid alterations enhance the survival of colorectal cancer cells under glucose-deprivation via autophagy.
Tan J; Wang HL; Yang J; Liu QQ; Li CM; Wang YQ; Fu LN; Gao QY; Chen YX; Fang JY
Theranostics; 2020; 10(13):5763-5777. PubMed ID: 32483417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
